My HPRA: Register

ILARIS

150 Mg/Ml Solution for Injection

Novartis Europharm LimitedEU/1/09/564/004

Main Information

Trade NameILARIS
Active SubstancesCANAKINUMAB
Strength150 Mg/Ml
Dosage FormSolution for Injection
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/09/564/004

Group Information

ATC CodeL04AC08 Interleukin inhibitors

Status

Authorised/WithdrawnAuthorised
Licence Issued23/02/2017
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print